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Introduction
Beta-blockade therapy during sepsis has a sound ratio-
nale in view of its cardiac, metabolic, inflammatory and
other effects [1]. Whether it is safe and efficacious in
both good prognosis and poor prognosis patients is yet
to be ascertained. We have developed a 72-h fluid-resus-
citated rat model of faecal peritonitis, where prognosis
can be accurately predicted as early as 6 h post-insult
based on the degree of myocardial depression (low
stroke volume, high heart rate)[2]. This model offers a
useful means of testing safety and efficacy.
Objectives
To compare dose-related haemodynamic effects of
esmolol at 6 hours in predicted survivors and non-survi-
vors from faecal peritonitis.
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Figure 1 *p < 0.05 vs. baseline (good prognosis group, dark blue bars, N = 4). #p < 0.05 vs. baseline (poor prognosis group, light blue
bars, N = 4).
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Methods
Instrumented male Wistar rats (350 ± 16 g) had sepsis
induced with intraperitoneal injection of faecal slurry.
Fluid resuscitation (10 ml/kg/h) was begun 2 h later. At
6 h, animals were divided into predicted survivors or
non-survivors depending on a stroke volume cut-off of
0.20 ml. After an additional 10-ml/kg fluid bolus, esmolol
was administered as a 500- µg/kg loading dose followed
by an increasing stepwise infusion (50 to 200 µg/kg/min
in 25- µg/kg/min increments 5 minutes apart). Heart
rate, stroke volume and mean arterial pressure were
recorded just prior to each dose increase. Repeated mea-
sures ANOVA and post-hoc Holm-Sidak test were used
to seek statistically significant differences.
Results
Baseline stroke volume at 6h was significantly lower in
poor prognosis animals (0.27 ± 0.07 vs. 0.18 ± 0.02 ml,
p < 0.05). Stroke volume increased with low dose esmolol
in predicted non-survivors, and this offset the reduction
in heart rate (Figure 1). Cardiac output was thus main-
tained in predicted non-survivors but fell significantly in
predicted survivors. Mean BP fell in parallel in both
groups, though significant changes were seen earlier in
predicted survivors.
Conclusions
Depending on their prognosis, septic rats show different
haemodynamic responses to a short-term esmolol infusion
at 6 h post-septic insult. Whether longer-term infusion is
beneficial or harmful to these subgroups will be the sub-
ject of future study.
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